Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

144.22 +0.21 (+0.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corp

< Previous 1 2 3 4 5 6 7 Next >
Deal Dispatch: TGI Fridays Goes Bankrupt, BHP Backtracks Comments And More M&A News
PE-owned TGI Fridays is looking for a bankruptcy deal, while ConocoPhillips and DigitalBridge Group seek to sell assets. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Apple's Week Of Peaks And Valleys: From Record iPhone Sales To Legal And Regulatory Challenges
Apple's rollercoaster week: facing U.S. probe, patent dispute, streaming services leaving App Store, but sets new iPhone sales record. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Apple Secures Victory In Masimo Patent Dispute With Token Damages Of $250
A Delaware jury has ruled in favor of Apple in a patent infringement case against Masimo, awarding Cupertino a symbolic $250 in damages. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
How Is The Market Feeling About Masimo?
Via Benzinga
$1000 Invested In Masimo 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
Via Benzinga
A Look Into Masimo Inc's Price Over Earnings
Via Benzinga
Masimo Stock Gets Relative Strength Rating Upgrade
The Relative Strength Rating for Masimo stock jumped into a higher percentile Tuesday, as it got a lift from 69 to 78. 
Via Investor's Business Daily
Why Masimo Stock Crushed the Market Today
The company seems to be effecting a smooth transition in its leadership. 
Via The Motley Fool
Masimo CEO Joe Kiani Resigns Following Politan Proxy Battle; Shares Jump
The company is facing numerous changes following a proxy battle with activist investor Politan. 
Via Investor's Business Daily
Masimo Names Interim CEO As Activist Board Members Step In; Joe Kiani Exits Amid Legal Clash
Masimo stock is up as the company announces leadership changes, reiterates strong financial guidance, and expects Q3 revenue of $495M-$515M. 
Via Benzinga
MASI Stock Earnings: Masimo Beats EPS, Beats Revenue for Q2 2024
MASI stock results show that Masimo beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
3 Healthcare Stocks to Buy Now: Q3 Edition
U.S. healthcare expenditures will grow by 5.6% annually, presenting a revenue tailwind for these healthcare stocks to buy now. 
Via InvestorPlace
Assessing Masimo: Insights From 6 Financial Analysts
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Masimo
Via Benzinga
Analyst Scoreboard: 5 Ratings For Masimo
Via Benzinga
What's Going On With Health Technology Company Masimo Shares Today?
Masimo reportedly considers an $850 million to $950 million bid for its consumer business amid active joint venture discussions while reporting strong Q2 healthcare revenue growth and record customer... 
Via Benzinga
Why Smartsheet Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Five Below Posts Weak Q1 Results, Joins Sprinklr, Dorian LPG And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
MASI Stock Earnings: Masimo Misses EPS, Beats Revenue for Q1 2024
MASI stock results show that Masimo missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch. 
Via InvestorPlace
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
How's AT&T Handling Things?
We've also got a look at 3M's spinoff, gold prices, and the beef industry. 
Via The Motley Fool
Can a New CEO Fix Boeing?
We also talk with e.l.f. Beauty CEO Tarang Amin about how the company is succeeding. 
Via The Motley Fool
Boeing's Leadership Shake-Up
And IWG CEO Mark Dixon talks with us about the global shift toward hybrid work. 
Via The Motley Fool
Tim Cook-Led Tech Giant Appeals To US Court For Overturning Import Ban On Its Apple Watches
Apple is appealing to reverse a U.S. import ban on certain Apple Watches stemming from a patent dispute with Masimo Corporation, arguing the patented Masimo wearable was theoretical and challenging the... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.